What is the global market size of Throat Lozenges Market?

Global Throat Lozenges Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.62 billion in 2023 to USD 9.92 billion by 2031, growing at a CAGR of 24.52% in the forecast period (2024-2032).

What is the key market trend for Global Throat Lozenges Market?

Global market assessment well-knownshows a dynamic market with some of standout tendencies and problems. The marketplace is driven via the habitual occurrence of throat irritations and the patron shift closer to self-care, boosting demand. However, competition from opportunity remedies and issues approximately sugar content material poses restraints. Medicated lozenges, mainly people with menthol, dominate the product sorts due to their verified soothing homes. North America leads the market with a high incidence of respiratory problems, while the Asia-Pacific area famous the fastest growth, pushed by using growing fitness cognizance. Key trends consist of the upward push of natural editions, sugar-free alternatives, and purposeful elements, aligning with the global shift in the direction of herbal and well-being-targeted treatments.

Throat Lozenges Market Size, Share, Growth Analysis, By Product type,(Medicated Throat Lozenges, and Non-Medicated Throat Lozenges.), By Flavor Variation (Menthol, Eucalyptus Oil, Honey, Ginger), By Ingredient Type(Cherry, Mint, Citrus, Berry), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35D2213 | Region: Global | Published Date: March, 2024
Pages: 206 | Tables: 93 | Figures: 76

Throat Lozenges Market News

March 2023: Taiho Pharmaceutical Co., Ltd. Has expanded its PITAS line of lozenges with the launch of PITAS Medical Troche, a new plum-flavored medicated lozenge (unique quasi-drug) in Japan. This marks the seventh product inside the PITAS series, recognized for its discreet layout that lets in users to appease their throats without being observed even even as speakme.

January 2023: The UK is facing a scarcity of cough and cold medicines, and pharmacy leaders are placing the blame squarely on the authorities's insufficient planning. They accuse the Rishi Sunak administration of failing to acknowledge the severity of the hassle (often phrased as "being in denial") as deliver chain issues keep to disrupt get admission to to vital medicines. This shortage consists of formerly with ease to be had cold and flu treatments.

January 2023: Founded in 1907, Jakemans stands as a renowned menthol lozenge brand. In January 2023, Jakemans delivered a brand new sugar-unfastened version of its loved traditional flavor, Throat

Throat Lozenges Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Throat Lozenges Market size was valued at USD 1.62 Billion in 2023 and is poised to grow from USD 2.02 Billion in 2024 to USD 12.35 Billion by 2032, growing at a CAGR of 24.52% during the forecast period (2025-2032).

The aggressive environment of the Throat Lozenges marketplace is characterized by means of the energetic participation of most important pharmaceutical and healthcare groups, in addition to area of interest gamers specializing in over-the-counter remedies. Key gamers interact in strategic initiatives, such as product innovation, mergers, acquisitions, and partnerships, to hold a competitive edge. Well-hooked up brands dominate the marketplace with their full-size product portfolios, leveraging their big distribution networks. However, the market also witnesses the access of smaller gamers supplying specific formulations, often emphasizing herbal or herbal substances. 'Reckitt Benckiser Group plc', 'GlaxoSmithKline plc', 'Mondelez International, Inc. (Halls)', 'Procter & Gamble Co. (Vicks)', 'Nestlé S.A.', 'Johnson & Johnson', 'Ricola AG', 'Bayer AG', 'Church & Dwight Co., Inc. (Ricola)', 'Pfizer Inc. (ChapStick)', 'Bionorica SE', 'Roxane Laboratories, Inc.', 'Wrigley Company', 'Mars, Incorporated (Fisherman's Friend)', 'Ernest Jackson & Company Ltd.', 'RemeGen Co., Ltd.', 'CF PharmTech, Inc.', 'Fertin Pharma A/S', 'Bach Remedy Ltd.', 'Plethico Pharmaceuticals Limited'

The recurrent prevalence of throat irritations, regularly associated with not unusual colds and respiration infections, serves as a primary driver. Consumers are looking for handy and effective answers for instant remedy, riding the demand for throat lozenges.

North America is anticipated to dominate the throat lozenges marketplace because of the region's excessive prevalence of breathing problems, inclusive of colds and flu. The call for throat lozenges is constantly excessive, riding market boom. The nicely hooked up healthcare infrastructure in North America ensures smooth accessibility to over-the-counter medicinal drugs, together with throat lozenges. This accessibility contributes to the dominance of the vicinity in the marketplace.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Throat Lozenges Market Size, Share, Growth Analysis, By Product type,(Medicated Throat Lozenges, and Non-Medicated Throat Lozenges.), By Flavor Variation (Menthol, Eucalyptus Oil, Honey, Ginger), By Ingredient Type(Cherry, Mint, Citrus, Berry), By Region - Industry Forecast 2025-2032

Throat Lozenges Market News

Throat Lozenges Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Throat Lozenges Market?

Who are the key vendors in the Throat Lozenges Market?

What is the key driver of Throat Lozenges Market?

What is the key market trend for Throat Lozenges Market?

Which region accounted for the largest share in Throat Lozenges Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300